Skin & Beauty

Ozempic and Hair Loss: Causes, Mechanisms, and Support

Reports of hair loss on Ozempic are climbing fast — clinical trial data and real-world pharmacovigilance studies suggest telogen effluvium affects roughly 25–33% of people who use GLP-1 agonists for significant weight loss. The good news is that this shedding has identifiable causes and targeted nutritional support can meaningfully reduce it. Here's what the science says and what you can do about it.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·8 min read
ozempic hair losssemaglutide hair losswegovy hair losstelogen effluviumGLP-1 side effects
Ozempic and Hair Loss: Causes, Mechanisms, and Support

Why Ozempic and Hair Loss Are Linked More Often Than You Think

Semaglutide — sold as Ozempic for type 2 diabetes management and Wegovy for weight loss — has become one of the most prescribed medications in modern medicine. With rapid adoption comes a growing body of post-market reports: hair thinning and shedding that often begins 2–4 months after starting the drug. A 2023 pharmacovigilance analysis drawing on the FDA Adverse Event Reporting System (FAERS) found that hair loss reports for semaglutide users were disproportionately elevated compared with baseline rates in the general population (Shi et al., Drug Safety 2023; PMID: 37358786).

The mechanism is not straightforward, and that's exactly why a functional-medicine framework is valuable here. Ozempic doesn't directly damage hair follicles. Instead, it sets off a cascade of downstream stressors — caloric restriction, nutrient depletion, hormonal shifts — that push growing follicles into a premature resting phase called telogen. Understanding each link in that chain gives you leverage to interrupt it.

Ozempic for Weight Loss: The Caloric Deficit Problem

Semaglutide works by mimicking GLP-1, a gut hormone that slows gastric emptying, amplifies insulin secretion, and — crucially — suppresses appetite at the hypothalamic level. In the STEP 1 trial, participants on 2.4 mg semaglutide lost an average of 14.9% of body weight over 68 weeks (Wilding et al., NEJM 2021; PMID: 33567185). That's a profound metabolic shift, and the body treats rapid weight loss much the same way it treats famine: it redirects resources away from non-essential functions like hair growth.

Telogen effluvium (TE) is the clinical term for this stress-triggered shedding. Normally around 10–15% of your scalp follicles are in the resting (telogen) phase at any given time. Under physiological stress — surgery, illness, crash dieting, or dramatic caloric restriction — that proportion can jump to 30–50%, leading to diffuse shedding 2–4 months later when those follicles cycle out.

The critical insight: the more rapidly you lose weight, the higher the TE risk. This applies whether you use semaglutide, undergo bariatric surgery, or follow an aggressive very-low-calorie diet. A 2014 review of post-bariatric hair loss found TE incidence ranging from 57–74% in patients who lost weight rapidly (Mechanick et al., Endocrine Practice 2013; PMID: 23529351). Ozempic accelerates the same process pharmacologically.

Wegovy and Hair Loss: What the Clinical Trials Actually Reported

In the STEP clinical trial program for Wegovy (semaglutide 2.4 mg), alopecia was listed as an adverse event in roughly 3% of participants in the trial report — but that figure almost certainly underestimates real-world prevalence. Clinical trial protocols use specific dermatological criteria, and patients often don't report early-stage shedding unless specifically prompted. Post-market surveillance and patient community data suggest rates closer to 25–33%.

Importantly, hair loss in these trials was classified as predominantly reversible. Most participants who experienced shedding saw regrowth within 6 months of stabilizing their weight or caloric intake. This aligns with the classic natural history of telogen effluvium: once the stressor resolves, follicles reenter the anagen (growth) phase. The clinical priority is therefore to identify and correct the modifiable nutritional deficiencies that prolong the shedding window.

Key Biomarkers to Test If You're Losing Hair on Semaglutide

BiomarkerOptimal RangeWhy It Matters for Hair
Serum ferritin≥ 70 ng/mLIron is rate-limiting for follicle cell division
Zinc (plasma)70–120 µg/dLCofactor for 5-alpha reductase and keratin synthesis
Vitamin D (25-OH)40–60 ng/mLRegulates hair follicle cycling via VDR
TSH + Free T3TSH 0.5–2.0, fT3 upper thirdHypothyroidism independently causes TE
Total protein / albuminAlbumin ≥ 4.0 g/dLSignals adequate protein for keratin precursors
BiotinPlasma or functional assayDeficiency rare but accelerated by poor intake

Low ferritin is the single most common correctable finding in patients with TE, and aggressive caloric restriction dramatically impairs iron absorption by reducing total food volume. If your ferritin sits below 40 ng/mL, hair regrowth is likely to stall regardless of other interventions (Rasheed et al., Dermatology 2013; PMID: 23380045).

Semaglutide and Hair Loss: The Nutrient Depletion Pathway

Semaglutide reduces appetite so effectively that many users eat far less than their micronutrient requirements. This isn't about macronutrient balance alone — it's a problem of total dietary volume. When you're consuming 1,200–1,500 kcal/day instead of 2,000+, you're likely falling short on zinc, iron, B vitamins, and essential amino acids unless your diet is exceptionally dense in these nutrients.

Zinc deserves special attention. It's required for DNA synthesis in rapidly dividing follicle matrix cells, and it's also a co-factor for the enzyme 5-alpha reductase — a key regulator of the hair growth cycle. Plasma zinc drops measurably in patients undergoing caloric restriction, and supplementation at 50 mg/day has been shown to reduce shedding in documented zinc-deficiency TE (Park et al., Annals of Dermatology 2009; PMID: 20520769). Ones includes zinc in its formula catalog at clinically targeted doses, calibrated based on a user's blood work rather than a one-size-fits-all approach.

Protein adequacy is equally non-negotiable. Hair is roughly 95% keratin, a protein polymer, and the anagen follicle has one of the highest rates of cell division in the body. Many GLP-1 users unknowingly fall into relative protein insufficiency — not because they're ignoring protein, but because their total intake drops alongside overall calories. Aiming for 1.2–1.6 g of protein per kilogram of body weight is a defensible minimum during active weight loss.

B vitamins, particularly riboflavin (B2) and biotin, support cellular energy metabolism in follicle keratinocytes. Riboflavin has a relatively low upper intake ceiling before excess appears in urine, but deficiency is a real concern during caloric restriction — if you're curious about how riboflavin fits into broader supplementation, the functional-medicine breakdown of riboflavin side effects covers dosing nuance in detail.

Compounded Semaglutide and Hair Loss: Does the Formulation Matter?

With brand-name Ozempic and Wegovy supply shortages, compounded semaglutide has become widely used. A common question is whether compounded versions carry the same hair-loss risk.

The short answer: the GLP-1 mechanism is the same regardless of formulation source. The caloric restriction, appetite suppression, and resulting nutrient depletion happen whether you're using brand-name or compounded semaglutide. What may differ is the support ecosystem around the medication — patients using compounded versions from telehealth providers sometimes receive less structured nutritional guidance, which could worsen the gap in micronutrient intake.

If you're using compounded semaglutide, applying the same biomarker-driven approach to nutritional monitoring is just as important — arguably more so, given the typically lighter clinical oversight. Getting your ferritin, zinc, vitamin D, and thyroid markers checked every 3–6 months is prudent.

Some compounded formulas also include additives like B12 or NAD+ precursors. While these aren't harmful at standard doses, there's limited evidence that adding B12 above sufficiency levels meaningfully reduces TE. The more impactful levers remain protein intake, iron status, and zinc.

For broader context on how supplementation interacts with chromium and metabolic markers during weight loss, understanding the full micronutrient picture becomes especially relevant during GLP-1 therapy.

The Hormonal and Thyroid Dimension

Weight loss of any significant magnitude can perturb thyroid function. Circulating T3 — the metabolically active thyroid hormone — often decreases transiently during caloric restriction, a phenomenon sometimes called "euthyroid sick syndrome" or "low T3 syndrome." Because thyroid hormones are essential for follicle cycling, even borderline low free T3 can extend the telogen phase and worsen shedding.

If your TSH is creeping upward (even within the "normal" laboratory range of 0.5–4.5) alongside GLP-1 therapy, it's worth requesting a full thyroid panel including free T3, free T4, and thyroid antibodies. Subclinical hypothyroidism at a TSH of 3.5 can produce meaningful hair effects even when most physicians don't treat at that level.

A functional-medicine clinician will typically look at the underlying causes of cholesterol and HDL imbalances alongside thyroid markers, since thyroid dysfunction affects lipid metabolism and multiple interconnected systems simultaneously.

What This Means for Your Formula

Personalized supplementation during GLP-1 therapy is not about throwing everything at the problem — it's about identifying your specific gaps and filling them precisely. Here's how the biomarker-driven approach maps to real supplementation decisions:

  • Zinc: Ones includes zinc in its ingredient catalog, dosed to your bloodwork findings. The therapeutic window for TE-related zinc deficiency in clinical research has been 25–50 mg elemental zinc daily — Ones targets this range based on your plasma zinc level rather than a default.
  • Vitamin D3 + K2 (MK-7): Vitamin D receptor (VDR) activity is essential for hair follicle cycling. Ones pairs D3 with MK-7 to ensure proper cofactor balance. Optimal D levels for hair are generally cited at 40–60 ng/mL 25-OH-D — most people on caloric restriction fall below this without targeted supplementation.
  • Ones' Adrenal Support blend: Rapid weight loss is a physiological stressor that elevates cortisol, which further disrupts follicle cycling. The Adrenal Support system blend in Ones' catalog is formulated to help modulate the HPA axis response during periods of metabolic stress — directly relevant to the stress-TE connection.

If your bloodwork reveals iron insufficiency, that's a clinical finding that warrants working with your physician on the appropriate iron supplementation form and dose (iron sulfate vs. bisglycinate, for instance), since Ones' formula focuses on the micronutrient gaps the AI identifies from your full lab panel.

Practical Protocol: Reducing Hair Loss During GLP-1 Therapy

  1. Get baseline labs before or within 4 weeks of starting semaglutide: ferritin, zinc, 25-OH vitamin D, full thyroid panel, CBC, and CMP.
  2. Set a protein floor: 1.2–1.6 g/kg body weight daily, prioritizing leucine-rich sources (eggs, fish, legumes).
  3. Don't let caloric restriction outrun your micronutrients: a registered dietitian familiar with GLP-1 therapy can build a nutrient-dense meal template within your reduced intake.
  4. Retest ferritin and zinc at 3 months: these are the biomarkers most likely to shift during active weight loss.
  5. Manage the pace of weight loss: slower loss (0.5–1 lb/week) is associated with less TE than aggressive restriction. Discuss dose titration timing with your prescriber.
  6. Address thyroid and cortisol: if labs show borderline thyroid or elevated morning cortisol, include those targets in your supplementation strategy.
  7. Give it time: telogen effluvium typically resolves within 3–6 months of stabilizing weight, even without intervention. Nutritional support shortens the duration and severity.

If you're also managing digestive side effects of weight-loss medications, the functional-medicine guide to probiotics for bloating addresses how GI support strategies can complement your overall protocol.

Key Takeaways

  • Ozempic and semaglutide don't directly damage follicles — hair loss is driven by rapid weight loss triggering telogen effluvium, compounded by nutrient depletion.
  • The most important biomarkers to monitor are ferritin (target ≥ 70 ng/mL), plasma zinc, 25-OH vitamin D, and thyroid function (TSH + free T3).
  • Protein intake is a non-negotiable foundation: 1.2–1.6 g/kg/day during active GLP-1-driven weight loss.
  • Compounded semaglutide carries the same hair-loss risk as brand-name formulations because the mechanism — appetite suppression and caloric restriction — is identical.
  • Telogen effluvium is usually reversible within 3–6 months once weight stabilizes; targeted nutritional support shortens the shedding window.
  • A personalized, biomarker-driven approach — identifying your specific deficiency profile rather than taking a generic hair supplement — is the most evidence-aligned strategy for managing GLP-1-related hair loss.

---

Always consult your healthcare provider before making changes to your medication protocol or starting new supplements. This article is for educational purposes and does not constitute medical advice.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading